This June, a 41-year-old man became the first European patient with Type 1 to come off insulin therapy after receiving a transplant of pancreatic islet cells using the BioHub technique. This therapy, engineered by the Diabetes Research Institute (DRI), protects transplanted islet cells from immune system attack.